SLNOEUR

Soleno Therapeutics INC

-$964.6M

Net Activity

Institutions Holding

227

Popularity Rank

#2589

Avg Weight

0.25%

Total Value

$2.2B

Ownership Trend

227 institutions currently hold SLNOEUR, with 127 net buyers and 135 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

135

Net Buying Institutions

127

Key Holders

View all 227 holding institutions

Quarterly Activity

Recent Activity

+$1.1B

Total Buy Value

$2.0B

Total Sell Value

New buy37
Trim74
Add90
Sold out61

127

Net Buyers

135

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding SOLENO THERAPEUTICS INC (SLNOEUR)?
Major stakeholders currently include Janus Henderson Group PLC ($237.6M), FMR LLC ($193.8M), Wellington Management Group LLP ($148.2M). Based on the latest 13F filings, there are a total of 227 tracked investment funds and institutions maintaining positions in SLNOEUR.
What is the overall institutional sentiment toward SLNOEUR recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $964.6M, driven by 127 managers accumulating shares while 135 reduced their exposure.
Which institutions have been selling or reducing their SLNOEUR positions?
In the latest period, 74 funds trimmed their holdings, and 61 managers completely exited their positions. The aggregate reported sell value was $2.0B.
Are there any notable investors adding SLNOEUR to their portfolios?
Yes, buying activity remains notable. 37 institutions opened new positions in {ticker}, and 90 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.1B.

Related Stocks